GFAP and Alzheimer disease: Expression of mRNA for the microglial marker IBA1 and the astrocytic marker GFAP were also significantly increased in AD compared to control samples, indicative of pathology‐associated microgliosis and astrogliosis; in contrast, expression of mRNA for the neuronal marker, RBFOX3, was similar in control and AD samples (Figure 6c).